Literature DB >> 18327785

The clinical spectrum associated with a chromosome 17 short arm proximal duplication (dup 17p11.2) in three patients.

Martine Doco-Fenzy1, Muriel Holder-Espinasse, Eric Bieth, Corinne Magdelaine, Marie-Claire Vincent, Maroun Khoury, Joris Andrieux, Feng Zhang, James R Lupski, Rabih Klink, Anouck Schneider, Odile Goze-Martineau, Jean-Marie Cuisset, Louis Vallee, Sylvie Manouvrier-Hanu, Dominique Gaillard, Bérengère de Martinville.   

Abstract

The p11.2-p12 region of human chromosome 17 is gene rich and composed of at least two genomically unstable domains: the Smith-Magenis syndrome region (17p11.2) and the Charcot-Marie-Tooth region (17p12), both of which are flanked by several low-copy repeat sequences. Homologous recombination between these flanking repeats results in either deletion- or duplication-associated phenotypes caused by a gene dosage effect. We report on the clinical phenotype of three patients presenting with either a 17p11.2 or 17p11.2p12 duplication, revealed by chromosome analysis and confirmed by fluorescent in situ hybridization analysis, high resolution genomic analysis of the 17p region using oligonucleotide array comparative genomic hybridization, and molecular studies with microsatellite markers. Two patients carry the 17p11.2 duplication, while the third one shows a larger duplication including the 17p12 region. The facial features observed in our patients include triangular face, full cheeks, smooth philtrum, thin upper lip, dental malocclusion, irregular eyebrows, and sparse hair, all of which are consistent with the pure proximal dup 17p phenotype. The patients' other clinical features are compared with previously published cases. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18327785     DOI: 10.1002/ajmg.a.32195

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Replicative mechanisms of CNV formation preferentially occur as intrachromosomal events: evidence from Potocki-Lupski duplication syndrome.

Authors:  Zhe Sun; Pengfei Liu; Xueyuan Jia; Marjorie A Withers; Li Jin; James R Lupski; Feng Zhang
Journal:  Hum Mol Genet       Date:  2012-11-16       Impact factor: 6.150

2.  Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS.

Authors:  Feng Zhang; Lorraine Potocki; Jacinda B Sampson; Pengfei Liu; Amarilis Sanchez-Valle; Patricia Robbins-Furman; Alicia Delicado Navarro; Patricia G Wheeler; J Edward Spence; Campbell K Brasington; Marjorie A Withers; James R Lupski
Journal:  Am J Hum Genet       Date:  2010-02-25       Impact factor: 11.025

3.  Nonrecurrent 17p11.2p12 Rearrangement Events that Result in Two Concomitant Genomic Disorders: The PMP22-RAI1 Contiguous Gene Duplication Syndrome.

Authors:  Bo Yuan; Tamar Harel; Shen Gu; Pengfei Liu; Lydie Burglen; Sandra Chantot-Bastaraud; Violet Gelowani; Christine R Beck; Claudia M B Carvalho; Sau Wai Cheung; Andrew Coe; Valérie Malan; Arnold Munnich; Pilar L Magoulas; Lorraine Potocki; James R Lupski
Journal:  Am J Hum Genet       Date:  2015-11-05       Impact factor: 11.025

4.  The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans.

Authors:  Feng Zhang; Mehrdad Khajavi; Anne M Connolly; Charles F Towne; Sat Dev Batish; James R Lupski
Journal:  Nat Genet       Date:  2009-06-21       Impact factor: 38.330

5.  Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.

Authors:  Jennifer L Roberts; Karine Hovanes; Majed Dasouki; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2013-11-02       Impact factor: 3.688

6.  Report of a patient with a de novo non-recurrent duplication of 17p11.2p12 and Yq11 deletion.

Authors:  Liliana Fernández-Hernández; María José Navarro-Cobos; Miguel Angel Alcántara-Ortigoza; Sandra Elena Ramos-Ángeles; Bertha Molina-Álvarez; Sinhué Díaz-Cuéllar; Bárbara Asch-Daich; Ariadna González-Del Angel
Journal:  Mol Cytogenet       Date:  2019-08-01       Impact factor: 2.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.